kurapwa renal cell carcinoma pathology inotsanangura mutengo

Kurapa Renal Cell Carcinoma: Pathology, Rondedzero, uye Mutengo weKufunga Kunzwisisa chirwere, marongero ekurapa, uye mari inosanganisirwa yerenal cell carcinoma (RCC) kwakakosha kuvarwere nemhuri dzavo. Iri gwara rakazara rinopa ongororo yakadzama yeRCC, ichitarisa pane yayo pathological maitiro, akasiyana nzira dzekurapa, uye mutengo zvinhu zvinosanganisirwa.

Kunzwisisa Renal Cell Carcinoma (RCC)

Renal cell carcinoma (kurapwa renal cell carcinoma pathology inotsanangura mutengo) imhando yegomarara reitsvo rinotangira muruta rweitsvo. Inoverengera huwandu hwekenza dzeitsvo. The prognosis uye nzira yekurapa zvakanyanya zvinoenderana nedanho regomarara, giredhi rayo, uye kuvapo kwechero metastases. Pathological kuongororwa kwetishu sampuli (biopsy) yakakosha pakuongorora kwakaringana uye kuita.

Pathological Features yeRCC

Pathologists vanoongorora matishu samples kuti vaone chaiyo mhando yeRCC, giredhi rayo (rinoratidza hukasha hwemaseru egomarara pasi pemaikorosikopu), uye nhanho yayo (inoratidza kuti gomarara rapararira zvakadii). Yakajairwa RCC subtypes inosanganisira yakajeka sero, papillary, chromophobe, uye kuunganidza duct carcinomas, imwe neimwe iine akasiyana microscope maficha. Iyo chaiyo pathological zvakawanikwa zvinokanganisa zvakanyanya kurapwa renal cell carcinoma pathology inotsanangura mutengo. Semuyenzaniso, mamota egiredhi epamusoro anowanzoda nzira dzehasha dzekurapa, zvinogona kukanganisa zvachose mutengo.

Maonerwo Ekurapa Renal Cell Carcinoma

The kurapwa zano reRCC rinosiyana zvichienderana nedanho uye rudzi rwegomarara. Nzira dzekurapa dzinosanganisira:

Kuvhiya

Kuvhiya kubviswa kweitsvo yakakanganisika (partial kana radical nephrectomy) ndiyo inowanzorapa yeRCC yemuno. Kukura kwekuvhiyiwa kunoenderana nekukura kwebundu uye nzvimbo.

Targeted Therapy

Dzidzo dzakanangwa dzinoshandisa mishonga inonangana nemasero egomarara, ichideredza kukuvadza kumaseru ane hutano. Mienzaniso inosanganisira tyrosine kinase inhibitors (TKIs) senge sunitinib uye pazopanib, uye mTOR inhibitors senge everolimus. Aya marapirwo anowanzo shandiswa kune yepamusoro kana metastatic RCC. Kubudirira uye mhedzisiro inosiyana zvichienderana nemushonga chaiwo uye nemurwere ega zvinhu.

Immunotherapy

Immunotherapy inoshandisa immune system yemuviri kurwisa cancer maseru. Immune checkpoint inhibitors, senge nivolumab uye ipilimumab, inowanzoshandiswa kumberi RCC. Mishonga iyi inosimudzira immune system kuti ione nekurwisa cancer maseru.

Radiation Therapy

Radiation therapy inogona kushandiswa kuderedza mapundu kana kuderedza zviratidzo mune zvimwe zviitiko. Inonyanya kushandiswa pamwe chete nezvimwe kurapwa modalities.

Chemotherapy

Chemotherapy hainyanyi kushandiswa semutsara wekutanga kurapwa yeRCC asi inogona kutariswa mune dzimwe nguva.

Mutengo weKufunga nezveRCC Kurapa

The mutengo ye kurapwa yeRCC inogona kusiyanisa zvakanyanya zvichienderana nezvinhu zvakasiyana, zvinosanganisira: Danho regomarara: Kenza dzepamusoro-danho rinowanzoda kurapwa kwakawanda uye kunodhura. Nzira yekurapa: Mishonga inotarirwa uye immunotherapies inowanzodhura kudarika kuvhiyiwa. Kureba kwekurapa: Nguva ye kurapwa inokanganisa zvachose mutengo. Chipatara uye mari yechiremba: Mari dzinogona kusiyana zvakanyanya zvichienderana nenzvimbo uye mupi wehutano. Mari yemishonga: The mutengo yemishonga, kusanganisira kurapa kwakanangwa uye immunotherapies, inogona kuva yakakura.

Kurapa Type	Inofungidzirwa Mutengo Range (USD)	Notes
Kuvhiya (Nephrectomy)	$30,000 - $100,000	Mutengo unosiyana zvakanyanya zvichienderana nechipatara uye chiremba anovhiya.
Targeted Therapy (pagore)	$100,000 - $200,000	Mutengo unoenderana nemushonga chaiwo uye dosage.
Immunotherapy (gore negore)	$150,000 - $300,000	Mutengo unoenderana nemushonga chaiwo uye dosage.

Disclaimer: Mitengo yemitengo ndeye fungidziro uye inogona kusiyana zvakanyanya. Bvunza nemutarisiri wako wehutano kuti uwane ruzivo rwemitengo yakasarudzika.

Zvishandiso uye Rumwe Rumwe Ruzivo

Kuti uwane rumwe ruzivo rwakadzama nezve renal cell carcinoma, ndapota bvunza chiremba wako kana kutumira kumasangano ane mukurumbira akadai seNational Cancer Institute (https://www.cancer.gov/) uye American Cancer Society (https://www.cancer.org/) Nekutarisirwa kwegomarara remunhu muChina, funga Shandong Baofa Cancer Research Institute.Yeuka, kukurumidza kuona uye nekukurumidza kurapwa kwakakosha pakuvandudza mhedzisiro muRCC. Mashoko aya ndeezvinangwa zvekudzidzisa uye haafanire kutorwa sezano rekurapa. Nguva dzose bvunzana nenyanzvi yezvehutano kuti uongororwe uye kurapwa kuronga maererano renal cell carcinoma pathology inotsanangura mutengo.